Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » AVVW--BOTTOM PLAY » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
StockRope  - posted
AVVW looks like a bottom play ,, easy mover here
 
TopRob  - posted
I think it will definitely run again. No luck at bottom .0007, so I'm in at .0008.
 
Doctoall  - posted
Guys we need some DD on the thread [Big Grin]
 
TopRob  - posted
A little old, but interesting news. They are also looking for a new CEO.
------------------------------

avVaa World Health Care Products Receives $250,000 Funding
Wednesday April 25, 8:30 am ET


LUMBY, British Columbia, April 25 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (OTC Bulletin Board: AVVW - News), a global biotechnology company offering therapeutic, 98% natural skin and health care products, announced today that on March 1, 2007, the Company completed financing agreements for $250,000 with private investors (the "investors"). The Company indicated the funds will be used for working capital purposes and to further its sales and distribution strategies.

Chairman of avVaa Jack Farley said, "The global market for professional skin care products is estimated at over $5 billion and is growing at double- digit rates [source: Kline & Company]. Our avVaa Care product line is positioned to capitalize on strong demand for effective, steroid-free skin care treatments. With our recent funding, we plan to accelerate our marketing and distribution efforts, setting the stage for Over-the-Counter product placement in both the U.S. and abroad. Our secondary product line of human hair care products and a line of Animal Care products will also significantly expand our sales opportunities, once our world distribution channels are established."

avVaa issued to the investors callable secured convertible notes totaling $250,000 with a 6% interest rate and a maturity of three years (the "Notes"). The Notes are convertible into shares of the Company's common stock on a formula basis. The Notes are secured with a secondary position on all of the Company's assets pursuant to the Security Agreement and the Intellectual Property Security Agreement entered into with the Investors. In addition, the Company granted the Investors warrants with a seven-year maturity, to purchase 10 million shares of the Company's common stock at an exercise price of $.002. Pursuant to the terms of a Registration Rights Agreement, the Company is required to register the shares underlying the Notes, as well as the shares to be issued pursuant to the Warrant within 45 days from the Closing Date and is required to have the registration statement declared effective within 120 days from the Closing Date.

The Company also reports that effective on April 19, 2007, the Board of Directors has accepted the resignation of Darrell Stevens as interim CEO and Director on the Board. The Board expressed its sincere appreciation of the outstanding work done by Darrell Stevens as interim CEO. Chairman Jack Farley indicated the Board is in the final process of selecting a new CEO, whose appointment will be announced in a forthcoming press release.

About avVaa World Health Care Products

avVaa World Health Care Products (OTC Bulletin Board: AVVW - News) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including dermatitis, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.

The second generation of avVaa's unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ worldwide animal care and products market. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.

CONTACT:

Jack Farley, Board Chairman and CEO of avVaa at 1-866-772-8822 or visit: http://www.avvaa.com or http://www.otcfn.com/avvw.

For Investor Relations: Rick McCaffrey of OTC Financial Network, 1-781- 444-6100 ext. 625, rick*otcfn.com.
 
TopRob  - posted
avVaa World Health Care Products Appoints Dr. Mario Zamora as Director to Its Board of Directors
Thursday April 26, 5:30 pm ET


LUMBY, British Columbia, April 26 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (OTC Bulletin Board: AVVW - News), a global biotechnology company offering therapeutic, natural skin and health care products, announced today that it has appointed a new director to its Board of Directors, Dr. Mario Zamora.

Dr. Zamora, a licensed Physician, received his PhD from University Autonomous of Nuevo Leon Medical School in Monterrey, Mexico. Dr. Zamora has a Master of Arts in Behavioral Sciences from University of Houston in Clear Lake, USA and is a Certified Christian Marriage and Family Therapist practicing in several parts of the southwestern United States and Mexico. He has been practicing in the medical psychotherapeutic field for over 20 years, has been a radio and TV talk show host on health issues for 15 years, and served as an advisor to several natural health companies for over a decade.

Dr. Mario Zamora said, "I am very excited to strengthen my existing relationship with avVaa. I've seen marked improvements in my patients' skin texture, overall appearance and comfort level, with the reduction of painful swelling and irritation, when using avVaa Care products. I look forward to working closely with the Board in helping the company increase product awareness to large populations suffering with Eczema, Psoriasis and Seborrheic Dermatitis."

Lorie Campbell-Farley, EVP of Sales and Marketing and Board Advisor for avVaa, stated, "Over the past year, it has been my pleasure to work with Dr. Zamora as he has taken on multiple studies of our products with extraordinary results. He has been instrumental in carving a market for us in the Texas region, and his expertise is a valuable addition to our board. Dr. Zamora reputation complements our outreach efforts in the national health care community."

Dr. Zamora studies with avVaa Care products reported the following: Rosacea - In damaged facial skin, avVaa Care products controlled this condition. With acne marks and damaged facial skin, including scars due to different factors, depending on the severity, avVaa Care products brought great results after 3 to 6 months of treatment. Hand and Foot Syndrome dermatitis caused by chemotherapy drugs, which affects the skin of hands and feet, including swollen, red, painful, cracking and peeling skin. With avVaa Care products, these effects are greatly alleviated after 3 to 6 months of treatment. avVaa Care products show promising results in aging skin where skin has lost its supple texture and appearance. With the use of avVaa Care products, a more natural and healthier appearance of the skin will be seen after a moderate length of time.
 
JimSC  - posted
0.008
AVVW: End-of-dilution run expected soon

* New CEO and new management:
* Recently got 250K$ private funding
that will end the dilution;
* Neuroskin skin products are ready to
hit the market;
* Any pr about the lineup of the
distributors will likely trigger the
run.
 
JimSC  - posted
O/S: 251 M shares

Market Cap: 200K$

-- Period -- -- High -- -- Low --
5-Day 0.0014 on 04/26/07 0.0007 on 04/24/07
20-Day 0.0020 on 04/04/07 0.0007 on 04/17/07
65-Day 0.0044 on 02/16/07 0.0007 on 04/17/07
100-Day 0.0100 on 01/10/07 0.0007 on 04/17/07
260-Day 0.0540 on 06/02/06 0.0007 on 04/17/07
Year to Date 0.0100 on 01/10/07 0.0007 on 04/17/07
 
JimSC  - posted
0.0007 X 0.0008
 
Lockman  - posted
http://stockcharts.com/h-sc/ui?s=AVVW&p=D&b=5&g=0&id=p91420059776

Looks like it could dip further.

Any great news?
 
TopRob  - posted
avVaa Rolls-Out Point-of-Purchase Displays for Pet and Equine Care Products to 30 North American Retailers
Tuesday May 8, 8:30 am ET


LUMBY, British Columbia, May 8 /PRNewswire-FirstCall/ -- avVaa World Health Care Products, Inc. (OTC Bulletin Board: AVVW - News) a global biotechnology company offering therapeutic, 98% all natural skin and health care products, announced today that the Company has rolled-out point-of-purchase displays to 30 North American retailers who sell avVaa Care Professional Animal Products for Pets and Equine. The visually appealing and descriptive product displays can be viewed online http://www.naturesgroom.com.

avVaa offers a full line of therapeutic, quality products for conscientious owners and the professionals who care for, groom and/or show their beloved pets, champion horses and other animals. avVaa Care's dermalustre® is a naturally-sourced mineral formula that is steroid-free and food grade safe for all ages of animals and people.

"Many equine and pet products on the market today have warnings on their labels stating 'Keep Out of Reach of Children,' or 'Inhaling Contents May Be Harmful or Fatal.' The new avVaa Care product line utilizes the healing powers of avVaa's NEUROSKIN formulas, which are currently sold to humans," said Barb Hazell, Vice President of Animal Care for avVaa Care.

"We are continuing our efforts to assist our Equine and Pet Retailers in the promotion of our dermalustre® Professional Equine and Pet Skin and Coat Treatment to meet demand for medically-safe, naturally sourced products," added Hazell.

dermalustre®'s unique formula does not coat the skin or hair but is absorbed deep into the skin and hair shaft resulting in treatment of the skin and hair on the inside as well as the outside. You can use dermalustre® as often as needed as it will not build up on the skin or hair. As a guideline only, we recommend treating the skin, coat, mane and tail daily with a light mist, and massage or brush in. Continue daily treatment until the health is restored. A weekly or bi-weekly treatment is usually all that's needed to maintain healthy skin and coat. After bath conditioners are not required, dermalustre® will provide detangling and conditioning keeping the skin, coat, mane and tail healthy. avVaa Care products have many other therapeutic uses, to learn more visit http://www.naturesgroom.com.

About avVaa World Health Care Products

avVaa World Health Care Products (OTC Bulletin Board: AVVW - News) is a global biotechnology company that specializes in effective, all natural, steroid-free therapeutic skin care products that improve the quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, OTC-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including dermatitis, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.

The Company's second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ animal care and products market in the USA. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.

For additional information on avVaa, contact Jack Farley, Board Chairman, at 1-866-772-8822 or visit: http://www.avvaa.com or http://www.otcfn.com/avvw. CONTACT: Investor Relations: Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625, rick*otcfn.com.
 
cactus33  - posted
hogs finally getting vol
 
onecentlotto  - posted
Looking good, starting the move up.
 
cactus33  - posted
moving again
 
TopRob  - posted
New high .0012 and still climbing. Volume already higher than last 5 days combined.
 
TopRob  - posted
Hot Dog! .0013 and looking good. Up 116%
 
JimSC  - posted
Thanks, TobRob, for keeping us informed.
I almost forgot AVVW -- I thought
she was dead.
 
TopRob  - posted
Good run today, now .0015 for 150%. It might go higher, but I'm out at .0014 for a big gain.
Good luck
 
dollar13  - posted
[Big Grin]

NICE RUN
 
TopRob  - posted
Wow! up 216% now .0019, I should have held a little longer.
 
SherriT  - posted
LOL - I was thinking about you when I saw the ask at .002 - guess I would have been fine to jump in when I saw it this morning.

Congrats on a nice pick!
 
dollar13  - posted
I was thinking about you


WHAT ABOUT ME [Big Grin]


LOL
 
SherriT  - posted
quote:
Originally posted by dollar13:
I was thinking about you


WHAT ABOUT ME [Big Grin]


LOL

LMAO - you too Dollar, but I didn't remember seeing you sell at .0014.... [Wink]
 
dollar13  - posted
THAT IS PROBABLY CAUSE I GOT IN TOO LATE.


0.0022 PRINTING
 
SherriT  - posted
Early or late, still making money....I thought it was dead too, or I would have been in early.
 
TopRob  - posted
quote:
Originally posted by SherriT:
LOL - I was thinking about you when I saw the ask at .002 - guess I would have been fine to jump in when I saw it this morning.

Congrats on a nice pick!

I was feeling fine when it was at .0015, but now I think I'm gonna be sick. Up 250% and climbing. Well I can't watch anymore, it's on to the next stock now.
 
dollar13  - posted
quote:
Originally posted by SherriT:
Early or late, still making money....I thought it was dead too, or I would have been in early.

YEP

I AGREE.
 
JimSC  - posted
I got in at 0.0008 when RBCM disappered
from the Ask, and the next day he reappeard
at Ask 0.0007. So I thought the bottom might
be at 0.0004. However, I estimated the MMs'
average cost was about 0.0015, and thought
it may take longer than I expected. I have
confidence on AVVW becasue some private
company offered themn a loan of 250K$. This
PR today was totally unexpected.
 
dollar13  - posted
I SHOULD KEEP MY EYES OPEN

NEXT TIME EH.
 
kidpolio  - posted
Wow this one ran up. was out today does anyone think it will gap or is it done?
 
jordanm  - posted
avVaa World Health Care Products Commences Marketing in the $4 Billion Over-the-Counter Skin Care Market


2007-05-09 08:30 ET - News Release


LUMBY, British Columbia, May 9 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. , a global biotechnology company offering therapeutic, 98% natural skin and health care products, announced today that it has commenced marketing brochures for NEUROSKIN(R) to Over-the-Counter retailers and drug stores in North America. NEUROSKIN(R) targets the over 40 million North Americans who suffer from skin related problems and spend nearly $4 billion annually on OTC product treatments.

See the brochures in full color online at www.avvaa.com for the following products: NEUROSKIN(R) Psoriasis Relief OTC Product; NEUROSKIN(R) Acne Treatment OTC Product; NEUROSKIN(R) Itch Relief OTC Product; and NEUROSKIN(R) Mild Skin Moisturizer Cosmetic Product.

Lorie Campbell-Farley, EVP Sales & Marketing of avVaa, said, "Relief from multiple chronic skin conditions has arrived. Our products are now available, without a prescription, at your local drug store. Increasing our products availability, supported by our ongoing marketing efforts, enables avVaa to start spreading the news that relief has arrived for the millions who currently suffer from psoriasis, seborrheic dermatitis and acne."

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, steroid-free therapeutic skin care products that improve the quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, OTC-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including dermatitis, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.

The Company's second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ animal care and products market in the USA. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.

CONTACT INFORMATION:

Jack Farley, Board Chairman of avVaa at 1-866-772-8822 or visit: http://www.avvaa.com or http://www.otcfn.com/avvw.

For Investor Relations: Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625, rick*otcfn.com.

Merle Goertz (West Coast) of avVaa World Health Care Products, 1-702-799-9655.
 
jordanm  - posted
GAPPER....
 
jordanm  - posted
.0024...up after the early MM games...kaboom soon...
 
jordanm  - posted
bid at .0027...kaboomm
 
JimSC  - posted
0.0008 X 0.0009

It hit 0.0029 last run.

The second round of PRs and run are
expected soon. Get in while the pps
is cheap.
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share